Diagnostic value of micrographia in Parkinson's disease: a study with [¹²³I]FP-CIT SPECT.

"Declarations Conflicts of interestThe authors report no competing interests. Mikael Eklund reports grants from the Finnish Parkinson Foundation (FPF), Turku University Hospital (TUH) and Finnish Medical Foundation (FMF) and pending grant applications from Funding: Maire Taponen Foundation and Finnish Brain Foundation related to submitted work. Simo Nuuttila reports grants from FPF, TUH, The Päivikki and Sakari Sohlberg Foundation (PSSF) and Finnish Alcohol Research Foundation (FARF), payment for manuscript writing from Turunmaan Duodecim association, support for attending a meeting from Turku University Foundation (TUF) Kosti Hämmärö fund, outside of submitted work. Elina Jaakkola reports grants from FPF outside of submitted work. Elina Mäkinen reports grants from FPF, TUF and Finnish Cultural Foundation (FCF) outside of submitted work. Emma Honkanen reports grants from TUF, TUH, FPF and FMF outside submitted work. Kirsi Murtomäki reports grants from FPF and The Hopital District of Helsinki and Uusimaa (HUS). Tuomas Mertsalmi reports grants from FPF, Finnish Norwegian Medical Foundation (FNMF) and Elias Aaltonen Foundation (EAF). Valtteri Kaasinen reports grants from FCF, PSSF, TUH related to submitted work and FARF outside of submitted work, consulting fees from Nordic Infucare Ab, Abbvie, Adamant Health and Orion Pharma, payments from Nordic Infucare, Abbvie and GE Healthcare, payment for expert testimony and support for attending meetings from Nordic Infucare Ab, has a patent concerning a novel method of minimal non-invasive diagnosis of Parkinson’s disease and is an expert for the Finnish patient injury board. Juho Joutsa, Kari Lindholm, Tero Vahlberg, Tommi Noponen, Toni Ihalainen, Tanja Nojonen, Reeta Levo and Filip Scheperjans report no conflicts of interest. Ethics approvalThe study was accepted by the local ethics committee (Ethics Committee, Hospital District of Southwest Finland) and was conducted according to the 1964 Declaration of Helsinki. Consent to participateInformed consent was obtained from all individual participants included in the study. Conflicts of interest The authors report no competing interests. Mikael Eklund reports grants from the Finnish Parkinson Foundation (FPF), Turku University Hospital (TUH) and Finnish Medical Foundation (FMF) and pending grant applications from Funding: Maire Taponen Foundation and Finnish Brain Foundation related to submitted work. Simo Nuuttila reports grants from FPF, TUH, The Päivikki and Sakari Sohlberg Foundation (PSSF) and Finnish Alcohol Research Foundation (FARF), payment for manuscript writing from Turunmaan Duodecim association, support for attending a meeting from Turku University Foundation (TUF) Kosti Hämmärö fund, outside of submitted work. Elina Jaakkola reports grants from FPF outside of submitted work. Elina Mäkinen reports grants from FPF, TUF and Finnish Cultural Foundation (FCF) outside of submitted work. Emma Honkanen reports grants from TUF, TUH, FPF and FMF outside submitted work. Kirsi Murtomäki reports grants from FPF and The Hopital District of Helsinki and Uusimaa (HUS). Tuomas Mertsalmi reports grants from FPF, Finnish Norwegian Medical Foundation (FNMF) and Elias Aaltonen Foundation (EAF). Valtteri Kaasinen reports grants from FCF, PSSF, TUH related to submitted work and FARF outside of submitted work, consulting fees from Nordic Infucare Ab, Abbvie, Adamant Health and Orion Pharma, payments from Nordic Infucare, Abbvie and GE Healthcare, payment for expert testimony and support for attending meetings from Nordic Infucare Ab, has a patent concerning a novel method of minimal non-invasive diagnosis of Parkinson’s disease and is an expert for the Finnish patient injury board. Juho Joutsa, Kari Lindholm, Tero Vahlberg, Tommi Noponen, Toni Ihalainen, Tanja Nojonen, Reeta Levo and Filip Scheperjans report no conflicts of interest."

"Funding Open Access funding provided by University of Turku (UTU) including Turku University Central Hospital. This work was supported by Turku University Hospital (VTR-funds), the Päivikki and Sakari Sohlberg Foundation, the Finnish Alcohol Research Foundation, the Finnish Parkinson Foundation, the Turku University Foundation."